United States Court of Appeals for the Federal Circuit
Teva Parenteral Medicines, Inc. Irvine, CA. Form 483 (Inspectional Observations). 7/13/09 – 7/24/09
Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) Due to Particulate Matter | Business Wire
Teva charts 300-plus layoffs at troubled California injectables plant
Teva Parenteral Medicines, Inc. - Irvine, CA - Local Business | Facebook
Rx Item-Metoclopramide 5Mg/Ml Inj Vial 25X2Ml By Teva Pharma
Articles about Teva Pharmaceuticals, Inc. | page 2
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Veronica Ureno - Technical Lead - Teva | LinkedIn
Eli Lilly & Co. v. Teva Parenteral Medicines, Inc. (Fed. Cir. 2012) | McDonnell Boehnen Hulbert & Berghoff LLP - JDSupra
Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) Due to Particulate Matter | Business Wire